Thanks to this 100% online program, you will carry out health promotion and education campaigns aimed at different audiences”

Public Health Surveillance is a fundamental aspect of identifying and controlling infectious and chronic diseases globally. In this regard, a recent World Health Organization report reveals that approximately 1.5 million people have died from Tuberculosis in recent years. 

This underlines the importance of effective surveillance for its control. 

In this regard, nurses play a key role in the collection and analysis of epidemiological data. They must therefore interpret this information accurately to understand disease dynamics and plan effective care.  

In this scenario, TECH implements a pioneering program in Public Health Surveillance for Nursing.

The academic itinerary will delve into the management of the most innovative self-monitoring systems, paying attention to factors such as critical control points, the establishment of preventive protocols or risk assessment. Likewise, the syllabus will delve into the procedures that nurses must follow when faced with alerts, epidemic outbreaks and emergencies. The didactic materials will also analyze a variety of techniques to prevent both communicable and non-communicable diseases, with emphasis on cancer. In this way, graduates will develop advanced competencies to monitor the status of individuals and plan programs to promote optimal Public Health. 

In addition, the program is delivered entirely online so that nurses can customize their study time. In addition, TECH employs its innovative learning system: Relearning. This allows professionals to consolidate the concepts of the syllabus in a progressive and natural way, without the need to resort to costly techniques such as traditional memorization. 

To access the Virtual Campus, all they need is an electronic device with an Internet connection. In this way, graduates will be able to enjoy the most dynamic educational resources on the market and experience a significant quality leap in their professional careers.    

This university program will equip you with the resources you need to overcome future challenges in Public Health Surveillance”

This Postgraduate diploma in Public Health Surveillance for Nursing contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical case studies presented by experts in Public Health and Health Management
• The graphic, schematic and practical contents with which it is conceived provide scientific and practical information on those disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

You will delve into the latest advances in Pharmacovigilance Monitoring Systems and be able to identify signals of potential risks associated with medicines”  

The program’s teaching staff includes professionals from the sector who contribute their work experience to this specializing program, as well as renowned specialists from leading societies and prestigious universities.  

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.  

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will acquire a comprehensive approach aimed at the prevention of chronic diseases, which will allow you to promote healthy and sustainable aging"

You will reinforce your knowledge through TECH's innovative Relearning methodology, which will ensure an effective assimilation of the subject"

Through this university program, nurses will perform health surveillance activities and contribute to the improvement of community health.  

The syllabus will analyze in detail the mechanisms for the design of health protection programs, as well as the interpretation of epidemiological data on chronic diseases.  Likewise, the syllabus will delve into the risk factors of cancer, enabling graduates to detect risk factors and apply prevention strategies. The didactic contents will also provide the most innovative tools to evaluate the quality of intervention studies.   

A high level syllabus that covers the latest scientific postulates in Clinical Epidemiology”

Module 1. Public Health Surveillance 

1.1. Protection, Prevention and Surveillance in Public Health: Classification, Evaluation, Management and Risk Control and Communication 

1.1.1. Health Protection and Prevention 
1.1.2. Health Surveillance and Risk Management 
1.1.3. Risk Communication Mechanisms and Limitations 

1.2. Self-control and Surveillance Systems: Hazard Analysis and Critical Control Points 

1.2.1. Establishment of Preventive Protocols 
1.2.2. Identification and Risk Assessment 
1.2.3. Implementation and Follow-up Control Points 

1.3. Research and Critical Analysis of Process and Outcome Indicators, Records, and Evaluation Systems Development and Innovation 

1.3.1. Research and Analysis of Indicators 
1.3.2. Recording and Evaluation for Efficient Data Management 
1.3.3. Innovation in Evaluation Systems 

1.4. Research in the Design, Implementation, and Impact Evaluation of Health Protection and Prevention Programs 

1.4.1. Mechanisms for the Design of Health Protection and Prevention Programs 
1.4.2. Implementation of Health Protection and Prevention Programs 
1.4.3. Analysis of the Impact of Health Protection and Prevention Programs 

1.5. Analysis and Interpretation of Epidemiological Data on Environmental Health: Surveillance, Estimation, Plans and Programs 

1.5.1. Importance of Environmental Health in Human Health. 
1.5.2. Exploration of Environmental Epidemiological Data 
1.5.3. Practical Application of Environmental Data Analysis 

1.6. Interpretation of Epidemiological Data on Chronic Diseases and Planning: Surveillance, Estimation, Design of Plans, Programs, and Screening 

1.6.1. Epidemiological Analysis of Chronic Diseases Importance of Monitoring 
1.6.2. Design and Development of Interventions for Chronic Diseases 
1.6.3. Epidemiological Surveillance and Disease Burden Analysis 

1.7. Research in Primary Prevention of Chronic Diseases: Health Protection 

1.7.1. Research in Primary Prevention of Chronic Diseases 
1.7.2. Applied Research in Health Prevention and Protection 
1.7.3. Impact Evaluation and Communication of Results 

1.8. Innovation in Pharmacovigilance Monitoring and Prevention Systems: Alerts and Preventive Interventions 

1.8.1. Importance of Pharmacovigilance Safety in the Use of Drugs 
1.8.2. Advances in Pharmacovigilance Monitoring Systems. 
1.8.3. Risk Prevention Through Preventive Interventions 

1.9. Models of Response to Alerts, Epidemic Outbreaks and Emergencies Development of Protocols and Procedures 

1.9.1. Response Strategies for Health Emergencies 
1.9.2. Development of Crisis Management Protocols 
1.9.3. Implementation and Evaluation of Emergency Response 

1.10. International Health and Innovation in International Cooperation for Epidemiological Surveillance 

1.10.1. International Health Global Perspective on Epidemiological Surveillance 
1.10.2. Innovation in International Cooperation for Epidemiological Surveillance 
1.10.3. Challenges and Future of International Cooperation in Health 

Module 2. Epidemiology and Prevention of Communicable and Non-communicable Diseases 

2.1. Epidemiology of Cancer:  Risk Factors and Primary Prevention  

2.1.1. Descriptive Epidemiology: Incidence, Mortality and Data Sources 
2.1.2. Cancer Risk Factors: Environmental and Occupational  
2.1.3. Other Factors: Ultraviolet Light, Infections, Radiation 

2.2. Risk Factors and Primary Prevention of Cancer: Lifestyle and Screening  

2.2.1. Primary Prevention Risk Factors and Prevention Strategies 
2.2.2. Legislative Measures  
2.2.3. Secondary Prevention  

2.3. Biological Mechanisms of Cardiovascular Disease  Estimation of Cardiovascular Risk and Population Prevention 

2.3.1. Ischemic Heart Disease and Stroke 
2.3.2. Epidemiological Indicators  
2.3.3. Classification of Cardiovascular Risk  
2.3.4. Prevention and Control of Cardiovascular Diseases 

2.4. Detection of Rare Diseases and Neonatal Screening 

2.4.1. Rare Diseases 
2.4.2. Newborn Screening Programs 
2.4.3. Neonatal Screening for Congenital Metabolic and Endocrinologic Diseases 

2.5. Comprehensive Approach to Chronic Disease Prevention for Healthy and Sustainable Aging 

2.5.1. Healthy Aging 
2.5.2. Active Aging 
2.5.3. Integrated Prevention 

2.6. Epidemiology of Communicable Diseases: Epidemiologic Surveillance Systems and Notifiable Disease Systems 

2.6.1. Causative Agents  
2.6.2. Time Periods  
2.6.3. Transmission  
2.6.4. Host and Susceptible Population  
2.6.5. Epidemiological Surveillance Systems 

2.7. Utility of Vaccines in the Prevention of Immunopreventable Infectious Diseases 

2.7.1. Analysis of the Importance of Vaccination in the Prevention of Infectious Diseases at the Individual and Community Levels 
2.7.2. Evolution of Vaccines:  Types of Vaccines Currently Available 
2.7.3. Mechanisms of Action of Vaccines and Their Impact on the Immune System 
2.7.4. Efficacy and Safety of Vaccines in the Prevention of Infectious Diseases 
2.7.5. Importance of Vaccination in Risk Groups and in the Prevention of Epidemics 
2.7.6. Logistics and Vaccination Programs at the International Level 
2.7.7. Economic and Social Impact of Vaccination in the Prevention of Infectious Diseases 
2.7.8. Research and Analysis of Barriers and Challenges in the Implementation of Vaccination Programs 
2.7.9. Strategies and Measures to Promote Vaccination and to Raise Public Awareness of its Importance 
2.7.10 Evaluation and Critical Analysis of the Scientific Literature Related to Vaccines and their Usefulness in the Prevention of Infectious Diseases 

2.8. Emerging Diseases Epidemic Outbreaks 

2.8.1. Factors Favoring Emerging Diseases 
2.8.2. New Agents and Diseases 
2.8.3. International Health Regulations (IHR) 
2.8.4. Epidemic Outbreaks. Study, Control and Measures: Chemoprophylaxis, Immunoglobulins and Vaccines  

2.9. Viral Hepatitis, HIV infection, AIDS, Sexually Transmitted Infections (STIs) and Tuberculosis 

2.9.1. Hepatitis A: Etiology, Epidemiology and Preventive Measures 
2.9.2. Hepatitis B: Etiology, Epidemiology and Preventive Measures 
2.9.3. Other Viral Hepatitis: Etiology, Epidemiology and Preventive Measures 
2.9.4. HIV: Etiology, Epidemiology and Preventive Measures 
2.9.5. Sexually Transmitted Infections (STIs): Etiology, Epidemiology, and Preventive Measures 
2.9.6. Tuberculosis: Etiology, Epidemiology and Preventive Measures 

2.10. Meningococcal Disease (MD) and Zoonosis: Epidemiology Prevention and Control 

2.10.1. Epidemiology of Meningococcal Disease 
2.10.2. Prevention and Control of Meningococcal Disease 
2.10.3. Epidemiology of Zoonoses 
2.10.4. Prevention and Control of Zoonoses

Module 3. Clinical Epidemiology 

3.1. Design and Quality Assessment of Intervention Studies in Epidemiology 

3.1.1. Intervention Studies, Types and Key Design Elements 
3.1.2. Ethical Aspects of Intervention Research 
3.1.3. Design of Specific Intervention Studies 
3.1.4. Tools for Assessing the Quality of Intervention Studies 
3.1.5. Critical Appraisal of Intervention Studies 
3.1.6. Importance of Design and Quality Assessment 

3.2. Pragmatic vs. Explanatory Randomized Clinical Trials 

3.2.1. Differentiation Between Pragmatic and Explanatory Clinical Trials 
3.2.2. Ethical Implications of Each Approach 
3.2.3. Critical Evaluation of the Methodology and Design of Each Type of Trial 
3.2.4. Application of Knowledge to Clinical Practice and Research 
3.2.5. Promotion of Critical Thinking and Analytical Skills 
3.2.6. Design and Conduct of Clinical Studies 

3.3. Design of Diagnostic Test Studies 

3.3.1. Selection of the Study Population and Definition of Inclusion and Exclusion Criteria 
3.3.2. Determination of the Study Design and Selection of the Reference Methodology 
3.3.3. Calculation of Diagnostic Accuracy and Analysis of Results 

3.4. Evaluation of the Quality of a Diagnostic Test Study 

3.4.1. Study Validity Analysis 
3.4.2. Evaluation of the Accuracy of the Diagnostic Test 
3.4.3. Analysis of the Clinical Utility of the Diagnostic Test 

3.5. Design and Quality Assessment of Prognostic Factor Studies 

3.5.1. Selection and Definition of Prognostic Factors 
3.5.2. Study Design and Selection of the Study Population 
3.5.3. Evaluation of the Quality of the Study and the Prognostic Model 

3.6. Evidence-based Clinical Recommendations: GRADE 1 

3.6.1. Systematic Review of the Scientific Literature Identification of Clinical Recommendations 
3.6.2. Quality of Evidence and Strength of Recommendations 
3.6.3. Clinical Recommendations Applicable to Clinical Practice 
3.6.4. Development of Clinical Protocol or Clinical Guideline Based on the Identified Recommendations 
3.6.5. Implementation and Follow-up of the Clinical Protocol or Guideline in Patient Care Evidence and Focus on Improving Clinical Outcomes 
3.6.6. Periodic Evaluation, through Monitoring of Clinical Outcome Indicators and Feedback from the Health Professionals Involved 

3.7. Evidence-based Clinical Recommendations: GRADE 2 

3.7.1. Analysis and Synthesis of the Available Evidence in the Scientific Literature for the Development of Recommendations 
3.7.2. Identification and Evaluation of the Quality of the Relevant Studies that Support the Clinical Recommendations 
3.7.3. Application of the Principles of the GRADE Methodology to Establish the Strength and Certainty of Clinical Recommendations 
3.7.4. Developing Clinical practice Guidelines that Incorporate Evidence-based Recommendations and that are Useful for Clinical Decision Making 
3.7.5. Periodic Updating and Revision of Clinical Recommendations Based on the Available Scientific Evidence 

3.8. Evaluation of the Quality of Care 

3.8.1. Quality Criteria and Standards from the Point of View of Safety 
3.8.2. Evaluation of the Effectiveness of the Results obtained through the Actions Evaluated of the Actions Evaluated and their Components 
3.8.3. Measurement of Patient Outcomes and Experiences, Patient-Reported Outcome  Measures (PROM) and Patient-Reported Experience Measures (PREM) 
3.8.4. Indicators for Assessing the Degree of Involvement, Participation and Satisfaction of Healthcare Professionals 

3.9. Incorporation of Patients' Values and Preferences: Shared Decisions 

3.9.1. Effective Communication and Understanding of Values and Preferences 
3.9.2. Education and Counseling on Treatment Options 
3.9.3. Facilitation of Shared Decision Making 

3.10. Patient Safety 

3.10.1. Identification and Recording of Adverse Events 
3.10.2. Analysis of Errors and Underlying Causes 
3.10.3. Implementation of Corrective Actions and Prevention Measures

The teaching materials of this program, elaborated by these specialists, have contents that are completely applicable to your professional experiences"